Related Experiment Video
Updated: Jun 13, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Biochemical Features and Clinical Factors Influencing Response to Surfactant Treatment Among Infants Born Late
Lucia Lanciotti1, Anna Sartori2, Manuela Simonato3
1Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.
Objective:
To evaluate main biophysically active surfactant components and inflammatory mediators, and to identify the factors associated with good response to surfactant, in late preterm infants with respiratory distress syndrome (RDS).
Study Design:
This was a prospective, multicenter, cohort study enrolling late (gestational age 34+0/7-36+6/7 weeks [late-PTRDS]) and moderately (gestational age 32+0/7-33+6/7 weeks, [moderately-PTRDS]) preterm infants with RDS. Term infants with no lung disease (term-NLD) were enrolled as controls. The concentration of disaturated-phosphatidylcholine (DSPC), surfactant protein-B (SP-B), total proteins, interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in epithelial lining fluids were measured by high-performance liquid chromatography-mass spectrometry, enzyme-linked immunosorbent assay, Lowry, or Luminex techniques, respectively, and corrected using plasma-to-bronchoalveolar lavage fluid urea ratio. Clinical data, including inspired oxygen fraction (FiO2) and preductal oxygen hemoglobin saturation (SpO2), were recorded in real-time.
Results:
We studied 55 late-PTRDS, 44 moderately-PTRDS, and 18 term-NLD infants. DSPC was lower in late-PTRDS (43 [24-124] mg/dL) than in term-NLD (249 [147-688] mg/dL, P < .001) but similar to that of moderately-PTRDS (30 [9-80] mg/dL, P = .083). SP-B, total proteins, IL-1β, IL-6, and tumor necrosis factor-α were similar between late-PTRDS and moderately-PTRDS. SP-B, total proteins, and IL-6 were significantly higher in late-PTRDS than term-NLD. Each hour of delay for surfactant administration, each 5-point increase in FiO2 threshold, and each 5-point decrease in preductal hemoglobin saturation SpO2/FiO2 ratio before surfactant treatment decreased the likelihood of good response by 12% (P = .002), 28% (P = .019) and 15% (P = .028), respectively.
Conclusions:
Late-PTRDS had DSPC and SP-B levels similar to moderately-PTRDS. Early administration, lower FiO2 threshold, and better oxygenation prior to surfactant treatment were associated with a better response to surfactant therapy.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
Related Concept Videos
Breathing
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-IV
Factors Affecting Drug Response: Overview